Abstract
RNAi interference (RNAi) is a powerful gene silencing technology that has immense potential for treating a vast array of human ailments, for which suppressing disease-associated genes may provide clinical benefit. Here, we review the development of RNAi as a therapeutic modality for neurodegenerative diseases affecting the central nervous system (CNS). We overview promising preclinical data for the application of RNAi in the CNS and discuss key challenges (e.g. delivery and specificity) that remain as these approaches transition to the clinic. © The Author 2011. Published by Oxford University Press. All rights reserved.
Cite
CITATION STYLE
Boudreau, R. L., Rodríguez-Lebrón, E., & Davidson, B. L. (2011). RNAi medicine for the brain: Progresses and challenges. Human Molecular Genetics, 20. https://doi.org/10.1093/hmg/ddr137
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.